Showing results (611-620 of 31,429) with videos related to
Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|August 24, 2011
Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamasesClaudia Scotta, Carlos Juan, Gabriel Cabot, et al.Antimicrobial Agents and Chemotherapy|August 24, 2011
ArmA methyltransferase in a monophasic Salmonella enterica isolate from foodSophie A Granier, Laura Hidalgo, Alvaro San Millan, et al.Antimicrobial Agents and Chemotherapy|August 24, 2011
Transmission of dapsone-resistant leprosy detected by molecular epidemiological approachesWei Li, Rama M Sakamuri, Danielle E Lyons, et al.Antimicrobial Agents and Chemotherapy|August 24, 2011
Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacinJason A Rosenzweig, Sheri M Brackman, Michelle L Kirtley, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatusZheng Fan, Luyang Cao, Yawen He, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Efficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant librarySanggu Kim, Yun-Cheol Kim, Hangfei Qi, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast ThailandVanaporn Wuthiekanun, Premjit Amornchai, Natnaree Saiprom, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Spider venom peptides for gene therapy of Chlamydia infectionVassili N Lazarev, Nadezhda F Polina, Marina M Shkarupeta, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype BLaura Monno, Annalisa Saracino, Luigia Scudeller, et al.Antimicrobial Agents and Chemotherapy|August 31, 2011
Nelfinavir and its active metabolite, hydroxy-t-butylamidenelfinavir (M8), are transferred in small quantities to breast milk and do not reach biologically significant concentrations in breast-feeding infants whose mothers are taking nelfinavirPaul J Weidle, Clement Zeh, Amy Martin, et al.Pageof 3,143